Improved efficacy to cytotoxic agents chemotherapy after immune checkpoint inhibitors exposure in metastatic gastric cancer

被引：0
|
作者：
Sagawa, Tamotsu
Sato, Yasushi
Hamaguchi, Kyoko
Hirakawa, Masahiro
Nagashima, Hiroyuki
Waga, Eriko
Fujikawa, Koshi
Takahashi, Yasuo
机构：
[1] Natl Hosp Org Hokkaido Canc Ctr, Div Gastroenterol, Sapporo, Hokkaido, Japan
[2] Tokushima Univ, Grad Sch Biomed Sci, Dept Gastroenterol & Oncol, Tokushima, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
297
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Salvage chemotherapy after treatment with immune checkpoint inhibitors in women with recurrent cervical cancer
    Wallam, Sara
    Dugan, Katherine
    Levinson, Kimberly
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 394 - 394
  • [32] The rest period between chemotherapy and immunotherapy influences the efficacy of immune checkpoint inhibitors in lung cancer
    Kang, Da Hyun
    Choi, Seong-woo
    Sun, Pureum
    Chung, Chaeuk
    Park, Dongil
    Lee, Song-, I
    Koh, Jeong Suk
    Kim, Yoonjoo
    Lee, Jeong Eun
    THORACIC CANCER, 2022, 13 (16) : 2346 - 2354
  • [33] Efficacy and safety of immune checkpoint inhibitors in young adults with metastatic melanoma
    Wong, Selina K.
    Blum, Steven M.
    Sun, Xiaopeng
    Silva, Ines P. Da
    Zubiri, Leyre
    Ye, Fei
    Bai, Kun
    Zhang, Kevin
    Ugurel, Selma
    Zimmer, Lisa
    Livingstone, Elisabeth
    Schadendorf, Dirk
    Serra-Bellver, Patricio
    Munoz-Couselo, Eva
    Ortiz, Carolina
    Lostes, Julia
    Huertas, Roberto M.
    Arance, Ana
    Pickering, Lisa
    V. Long, Georgina
    Carlino, Matteo S.
    Buchbinder, Elizabeth I.
    Vazquez-Cortes, Leticia
    Jara-Casas, Diego
    Marquez-Rodas, Ivan
    Gonzalez-Espinoza, Ivan R.
    Balko, Justin M.
    Menzies, Alexander M.
    Sullivan, Ryan J.
    Johnson, Douglas B.
    EUROPEAN JOURNAL OF CANCER, 2023, 181 : 188 - 197
  • [34] Integration of Biologic Agents With Cytotoxic Chemotherapy in Metastatic Colorectal Cancer
    Jain, Vikram K.
    Hawkes, Eliza A.
    Cunningham, David
    CLINICAL COLORECTAL CANCER, 2011, 10 (04) : 245 - 257
  • [35] Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients
    Jingjing Zhang
    Lei Wang
    Shasha Zhang
    Ruijie Cao
    Yufei Zhao
    Yue Zhao
    Yanrong Song
    Zhanjun Guo
    BMC Cancer, 24
  • [36] Association of gastric acid suppression with efficacy of immune checkpoint inhibitors (ICIs) in advanced cancer patients
    Izawa, Naoki
    Shiokawa, Hisae
    Onuki, Risa
    Hamaji, Koki
    Furuya, Naoki
    Ohashi, Hiroyuki
    Nishi, Tomohiro
    Kasugai, Shigeru
    Arai, Hiroyuki
    Doi, Ayako
    Horie, Yoshiki
    Hirakawa, Mami
    Mizukami, Takuro
    Ogura, Takashi
    Tsuda, Takashi
    Sunakawa, Yu
    Nakajima, Takako
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Association of gastric background mucosa status with the efficacy of immune checkpoint inhibitors in patients with unresectable advanced gastric cancer
    Kamijo, Y.
    Nagata, Y.
    Suzuki, H.
    Kunimoto, H.
    Seki, A.
    Sekino, Y.
    Sakon, M.
    Ushimaru, H.
    Hara, E.
    ANNALS OF ONCOLOGY, 2024, 35 : S190 - S190
  • [38] Alpha-fetoprotein predicts the treatment efficacy of immune checkpoint inhibitors for gastric cancer patients
    Zhang, Jingjing
    Wang, Lei
    Zhang, Shasha
    Cao, Ruijie
    Zhao, Yufei
    Zhao, Yue
    Song, Yanrong
    Guo, Zhanjun
    BMC CANCER, 2024, 24 (01)
  • [39] Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer
    Han, Xiling
    Chang, Wei-wei
    Xia, Xiaoping
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer
    Sivapiragasam, Abirami
    Kumar, Prashanth Ashok
    Sokol, Ethan S.
    Albacker, Lee A.
    Killian, Jonathan K.
    Ramkissoon, Shakti H.
    Huang, Richard S. P.
    Severson, Eric A.
    Brown, Charlotte A.
    Danziger, Natalie
    McGregor, Kimberly
    Ross, Jeffrey S.
    CANCER MEDICINE, 2021, 10 (01): : 53 - 61
12345